companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

CONSULPRINT

STITTSVILLE-Canada

Company Name:
Corporate Name:
CONSULPRINT
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 46 Manchester St,STITTSVILLE,ON,Canada 
ZIP Code:
Postal Code:
K2S1C5 
Telephone Number: 6138310604 
Fax Number:  
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
874112 
USA SIC Description:
Printing Consultants 
Number of Employees:
1 to 4 
Sales Amount:
$500,000 to $1 million 
Credit History:
Credit Report:
Very Good 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
CONTINENTAL PRICE ELECTRICAL CONT
CONTINENTAL ELECTRIC CONTRACTORS
CONTINENTAL ELECTRIC CONTRS
Next company profile:
CONNOLLY & MC NAMARA
CONNER H L ARCH
CONNECTING THE THOUGHTS










Company News:
  • label - Food and Drug Administration
    Finerenone is a nonsteroidal, selective antagonist of the mineralocorticoid receptor (MR), which is activated by aldosterone and cortisol and regulates gene transcription Finerenone blocks MR mediated sodium reabsorption and MR overactivation in both epithelial (e g , kidney) and nonepithelial (e g , heart, and blood vessels) tissues
  • KERENDIA English Product Monograph - Bayer
    Finerenone is a nonsteroidal, selective antagonist of the mineralocorticoid receptor (MR) Finerenone binds to the MR and blocks the binding of aldosterone, a component of the renin-angiotensin-aldosterone-system (RAAS)
  • Prescribing Information | KERENDIA® (finerenone)
    Review the prescribing information for KERENDIA® (finerenone) See safety and full prescribing info
  • Kerendia: Package Insert Prescribing Information - Drugs. com
    Kerendia package insert prescribing information for healthcare professionals Includes: indications, dosage, adverse reactions and pharmacology
  • DailyMed - KERENDIA- finerenone tablet, film coated
    12 1 Mechanism of Action - Finerenone is a nonsteroidal, selective antagonist of the mineralocorticoid receptor (MR), which is activated by aldosterone and cortisol and regulates gene
  • Kerendia (Bayer Healthcare Pharmaceuticals Inc. ): FDA Package Insert
    Bayer Healthcare Pharmaceuticals Inc : Kerendia is indicated to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure
  • ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
    The use of finerenone in patients with moderate hepatic impairment may require additional monitoring due to an increase in finerenone exposure Additional serum potassium monitoring and adaptation of monitoring have to be considered according to patient characteristics (see sections 4 2 and 5 2)
  • Kerendia, INN-finerenone - medicines
    Kerendia contains the active substance finerenone Finerenone works by blocking the action of certain hormones (mineralocorticoids) that can damage your kidneys and heart Kerendia is used for the treatment of adults with chronic kidney disease (stage 3 and 4 with abnormal presence of the protein albumin in the urine) associated with type 2
  • Kerendia Prescribing Information
    Finerenone is a nonsteroidal, selective antagonist of the mineralocorticoid receptor (MR), which is activated by aldosterone and cortisol and regulates gene transcription Finerenone blocks MR mediated sodium reabsorption and MR overactivation in both epithelial (e g , kidney) and nonepithelial (e g , heart, and blood vessels) tissues
  • Finerenone (KERENDIA) National Drug Monograph April 2022
    Description Mechanism of Action • Finerenone is a nonsteroidal, selective mineralocorticoid receptor antagonist (MRA) that blocks sodium reabsorption, and mineralocorticoid receptor overactivation in the kidney as well as the heart and blood vessels Per the product information, mineralocorticoid receptor overactivation is thought to contribute to fibrosis and inflammation Finerenone has a




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer